Alert: Claims Focus on AeroVironment's Reliance on a Single-Vendor Bespoke Contract That Allegedly Left Investors Exposed When the Space Force Shifted to Multi-Vendor Commercial...
SEATTLE, June 10, 2026 /PRNewswire/ -- RVL Strength, a Seattle-based fitness equipment company, today officially launches its flagship product, RVL Wings. This single and...
Brings more than two decades of leadership in cloud communications and enterprise softwareWill focus on scaling direct-to-enterprise motion, expanding strategic partnerships, and driving broader...
Trusted by eight of the world's top 10 retailers and CPG companies, Tredence powers $2 trillion in global retail revenue, delivering AI transformation at...
Class Actions Seeks to Represent Untold Number of Caregivers Who Appealed Denials from the VA's Program of Comprehensive Assistance for Family Caregivers
WASHINGTON, Aug. 12,...
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Rocket Pharmaceuticals class action lawsuit – captioned Ho v. Rocket Pharmaceuticals, Inc., No. 25-cv-10049 (D.N.J.) – seeks to represent purchasers or acquirers of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) securities and charges Rocket Pharmaceuticals and one of Rocket Pharmaceuticals’ top executives with violations of the Securities Exchange Act of 1934. A subsequently filed case is captioned Yankov v. Rocket Pharmaceuticals, Inc., No. 25-cv-13532 (D.N.J.).
Conference Unites Diverse Disciplines to Explore the Expanding Role of Artificial Intelligence in Creativity, Computation, and Connection.
VANCOUVER, BC, Aug. 6, 2025 /PRNewswire/ -- From...
SAN DIEGO, Aug. 4, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Rocket Pharmaceuticals class action lawsuit...
SAN JOSE, Calif., Aug. 1, 2025 /PRNewswire/ -- Reallusion proudly marks its 25th anniversary with a transformative leap into the future of animation, launching...
Total revenue in the quarter of $304.9 million grew 15% year-over-year and exceeded outlook
Gross margin improved to 42%, with gross profit increasing 19% year-over-year exceeding...